Peptide Source Tracker

Swiss Chems Review

swisschems.is

Active — FDA warning letterSince 2024-12-10

Peptide Source Tracker is independent and not affiliated with Swiss Chems.

The FDA sent Swiss Chems a warning letter in December 2024 alleging unapproved-drug claims on semaglutide and retatrutide products. A warning letter is an allegation of violations, not a finding of guilt. The letter-named products no longer appear in the catalog we crawled, and the store continues to operate.

Published rubric

Scorecard

Documentationunknownunverified1.5/3
Testingunknownunverified1.5/3
Payment safetyunknownunverified1.5/3
Track recordagency warning letter1/3
Total score4.6†out of 10

Documented history

Record

FDA warning letter alleging unapproved-drug claims

FDA Warning Letter 695663 alleged unapproved-drug claims involving semaglutide and retatrutide. The letter-named products were no longer present in the 2026-08-26 crawled catalog.

Sources

Facts

Domainswisschems.is
StatusActive — FDA warning letter
Last verified
TestingTesting documentation unconfirmed
PaymentsPayment methods unconfirmed

From the operator

Compare against a fully documented vendor
Curo publishes a verifiable COA for every lot and takes card payment — see the documentation standard this tracker scores against.
See Curo's COAs

Related reviews

Pure RawzUmbrella LabsPrime Peptides
Compare all vendors →